Assessing the Risk of Tuberculosis Relapse Development during the Period of Stabilization of the COVID-19 Epidemic
https://doi.org/10.58838/2075-1230-2024-102-4-42-46
Abstract
The objective: to evaluate risk factors for tuberculosis relapse development during stabilization of the COVID-19 situation.
Subjects and Methods. 165 patients over 18 years of age were enrolled in the observational comparative study, those patients were followed up due to respiratory tuberculosis relapses in 2021-2023. Risk factors for early and late relapses that occurred during the pandemic (2021-2022) and post-pandemic (2023) periods were analyzed. They included age, gender, accommodation, social status, imprisonment, smoking, alcohol and substances abuse, comorbidities, clinical forms of tuberculosis, presence of cavities, bacterial excretion, and drug resistance of Mycobacterium tuberculosis.
Results. The data obtained confirmed the assumption that the COVID-19 pandemic had led to changes in social and medical-biological risk factors for tuberculosis relapse.
About the Authors
M. V. Vershinina
Moscow Regional Clinical TB Dispensary; M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
Maria V. Vershinina, Doctor of Medical Sciences, Phthisiologist, Pulmonologist, Professor of Phthisiology Department
11 Bd. 1 Borby Sq., Moscow, 127030
Phone: +7 (496) 588-41-29
A. I. Shevchenko
Kuban State Medical University, Russian Ministry of Health; Clinical TB Dispensary, Ministry of Health of Krasnodarsky Kray
Russian Federation
Russian Federation
Andrey I. Shevchenko, Candidate of Medical Sciences, Associate Professor of Infectious Diseases and Phthisiopulmonology Department
4 Mitrofana Sedina St., Krasnodar, 350063
Phone: + 7 (861) 268-36-84
R. I. Ludanny
Moscow Regional Clinical TB Dispensary
Russian Federation
Russian Federation
Ruslan I. Ludanny, Candidate of Biological Sciences, Biologist
11 Bd. 1 Borby Sq., Moscow, 127030
Phone: +7 (496) 588-41-29
T. I. Vorobieva
Moscow Regional Clinical TB Dispensary
Russian Federation
Russian Federation
Tatiana I. Vorobieva, Head of Consulting and Diagnostic Department
11 Bd. 1 Borby Sq., Moscow, 127030
Phone: +7 (496) 588-41-29
O. D. Baronova
Moscow Regional Clinical TB Dispensary; M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
Olga D. Baronova, Doctor of Medical Sciences, Deputy Head Physician for Out-Patient Medical Care, Professor of Phthisiology Department
11 Bd. 1 Borby Sq., Moscow, 127030
Phone: +7 (496) 588-41-29
References
1. Vasilyeva I.A., Testov V.V., Sterlikov S.A. Tuberculosis situation in the years of the COVID-19 pandemic – 2020-2021. Tuberculosis and Lung Diseases, 2022, vol. 100, no. 3, pp. 6-12. (In Russ.)
2. Smerdin S.V., Sheshelyakina N.N., Shevchenko A.I., Plekhanova M.A., Ludanny R.I., Vorobyeva T.I. Stratification of risks of tuberculosis relapses during the pandemic of the novel coronavirus infection. Tuberculosis and Lung Diseases, 2023, vol. 101, no. 2, pp. 87-93. (In Russ.)
3. Stupak V.S., Zubko A.V., Manoshkina E.M., Kobyakova O.S., Deev I.A., Enina E.N. Healthcare in Russia during the COVID-19 pandemic: challenges, systemic issues, and addressing priorities. Russian Journal of Preventive Medicine, 2022, vol. 25, no. 11, pp. 21-27. (In Russ.)
4. Global tuberculosis report 2022. Geneva, World Health Organization, 2022. Available: https://iris.who.int/handle/10665/363752 Accessed July 01, 2024
Review
For citations:
Vershinina M.V., Shevchenko A.I., Ludanny R.I., Vorobieva T.I., Baronova O.D. Assessing the Risk of Tuberculosis Relapse Development during the Period of Stabilization of the COVID-19 Epidemic. Tuberculosis and Lung Diseases. 2024;102(4):42-46. (In Russ.) https://doi.org/10.58838/2075-1230-2024-102-4-42-46
Views:
245
Email this article 